News
FDA approves artificial heart valve
On June 17, the U.S. Food and Drug Administration (FDA) approved the SAPIEN 3 Transcatheter Heart Valve (THV) for patients with aortic valve stenosis.…
FDA mandates removal of trans fats in processed foods
On June 16, the U.S. Food and Drug Administration (FDA) announced that food manufacturers will have 3 years to remove partially hydrogenated oils, the…
FDA issues alert for facial soft tissue fillers
On May 28, the U.S. Food and Drug Administration (FDA) issued an alert about the possibility of rare, but serious, injuries that may occur…
FDA approves drug for rare lung disease
On May 28, the U.S. Food and Drug Administration (FDA) approved Rapamune (sirolimus), to treat lymphangioleiomyomatosis, a rare, progressive lung disease that primarily affects…
FDA approves treatments for irritable bowel syndrome
On May 27, the U.S. Food and Drug Administration (FDA) approved Viberzi (eluxadoline) and Xifaxan (rifaximin) for irritable bowel syndrome with diarrhea in adult…
FDA approves new spinal cord stimulation system for pain
On May 8, the U.S. Food and Drug Administration (FDA) approved the Senza spinal cord stimulation (SCS) system to help manage chronic intractable pain…
FDA approves artificial heart valve
On June 17, the U.S. Food and Drug Administration (FDA) approved the SAPIEN 3 Transcatheter Heart Valve (THV) for patients with aortic…
FDA mandates removal of trans fats in processed foods
On June 16, the U.S. Food and Drug Administration (FDA) announced that food manufacturers will have 3 years to remove partially hydrogenated…
FDA issues alert for facial soft tissue fillers
On May 28, the U.S. Food and Drug Administration (FDA) issued an alert about the possibility of rare, but serious, injuries that…
FDA approves drug for rare lung disease
On May 28, the U.S. Food and Drug Administration (FDA) approved Rapamune (sirolimus), to treat lymphangioleiomyomatosis, a rare, progressive lung disease that…
FDA approves treatments for irritable bowel syndrome
On May 27, the U.S. Food and Drug Administration (FDA) approved Viberzi (eluxadoline) and Xifaxan (rifaximin) for irritable bowel syndrome with diarrhea…
FDA approves new spinal cord stimulation system for pain
On May 8, the U.S. Food and Drug Administration (FDA) approved the Senza spinal cord stimulation (SCS) system to help manage chronic…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.